RubinGSpagnutGMorandiFValerioECutroneM.Subcutaneous fat necrosis of the newborn. Clin Case Rep. 2015;3:1017-1020. doi:10.1002/ccr3.423.
2.
ZebADarmstadtGL.Sclerema neonatorum: a review of nomenclature, clinical presentation, histological features, differential diagnoses and management. J Perinatol. 2008;28:453-460. doi:10.1038/jp.2008.33.
3.
CookJSStoneMSHansenJR.Hypercalcemia in association with subcutaneous fat necrosis of the newborn: studies of calcium regulating hormones. Pediatrics. 1992;90(1pt 1):93-96.
4.
CoondooALahiryRChoudhuryASenguptaS.Tender skin nodules in a newborn. Indian J Dermatol. 2013;58:328. doi:10.4103/0019-5154.113983.
5.
FarooqueAMossCZehnderDHewisonMShawNJ.Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis. Br J Dermatol. 2009;160:423-425. doi:10.1111/j.1365-2133.2008.08844.x.
6.
SharataHPostellonDCHashimotoK.Subcutaneous fat necrosis, hypercalcemia, and prostaglandin E. Pediatr Dermatol. 1995;12:43-47.
7.
ShumerDEThakerVTaylorGAWassnerAJ.Severe hypercalcemia due to subcutaneous fat necrosis: presentation, management and complications. Arch Dis Child Fetal Neonatal Ed. 2014;99:F419-F421. doi:10.1136/archdischild-2014-306069.
8.
Pérez MartínezECamprubí CamprubíMRamos CebriánMet al. Treatment with bisphosphonates in severe hypercalcemia due to subcutaneous fat necrosis in an infant with hypoxic-ischemic encephalopathy. J Perinatol. 2014;34:492-493.